Recent studies using ProteoSep show that the protein patterns of individual strains of bacteria can be analyzed and graphically mapped to create detailed, unique "fingerprints" of the strain.

This new and powerful protein separation technology designed to characterize and "map" complex protein mixtures could prove useful to forensic scientists who are concerned with the source of biological pathogens such as anthrax. ProteoSep, a new proteomics technology, was developed by Eprogen to address the need for improved analytical techniques in high-throughput protein analysis environments.

In addition to bacterial pathogen fingerprinting, ProteoSep has been demonstrated for the monitoring of disease progression, the characterization of cell lines and drug efficacy studies.